Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 616 AL 630

Is the Assessment of 5 Meters of Gait with a Single Body-Fixed-Sensor Enough to Recognize Idiopathic Parkinson's Disease-Associated Gait?

Micó-Amigo ME, Kingma I, Faber GS, Kunikoshi A, van Uem JMT, van Lummel RC, Maetzler W, van Dieën JH.

Ann Biomed Eng. 2017 May;45(5):1266-1278. doi: 10.1007/s10439-017-1794-8. Epub 2017 Jan 20.

Reprint of "Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease"

Balestrino R, Martinez-Martin P.

J Neurol Sci. 2017 Mar 15;374:3-8. doi: 10.1016/j.jns.2017.01.026. Epub 2017 Jan 12.

Gut microbiota: A player in aging and a target for anti-aging intervention

Vaiserman AM, Koliada AK, Marotta F.

Ageing Res Rev. 2017 May;35:36-45. doi: 10.1016/j.arr.2017.01.001. Epub 2017 Jan 18.

Dopaminergic modulation of multi-muscle synergies in postural tasks performed by patients with Parkinson's disease

Falaki A, Huang X, Lewis MM, Latash ML.

J Electromyogr Kinesiol. 2017 Apr;33:20-26. doi: 10.1016/j.jelekin.2017.01.002. Epub 2017 Jan 11.

Safinamide: A Review in Parkinson's Disease

Blair HA, Dhillon S.

CNS Drugs. 2017 Feb;31(2):169-176. doi: 10.1007/s40263-017-0408-1.

Smart Gait-Aid Glasses for Parkinson's Disease Patients

Ahn D, Chung H, Lee HW, Kang K, Ko PW, Kim NS, Park T.

IEEE Trans Biomed Eng. 2017 Oct;64(10):2394-2402. doi: 10.1109/TBME.2017.2655344. Epub 2017 Jan 19.

Positive effects of intermittent fasting in ischemic stroke

Fann DY, Ng GY, Poh L, Arumugam TV.

Exp Gerontol. 2017 Mar;89:93-102. doi: 10.1016/j.exger.2017.01.014. Epub 2017 Jan 20.

Palmitoylation mechanisms in dopamine transporter regulation

Rastedt DE, Vaughan RA, Foster JD.

J Chem Neuroanat. 2017 Oct;83-84:3-9. doi: 10.1016/j.jchemneu.2017.01.002. Epub 2017 Jan 20.

The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel

Pedersen SW, Suedmeyer M, Liu LW, Domagk D, Forbes A, Bergmann L, Onuk K, Yegin A, van Laar T.

J Multidiscip Healthc. 2017 Jan 4;10:13-27. doi: 10.2147/JMDH.S111369. eCollection 2017.

Essential pitfalls in "essential" tremor

Espay AJ, Lang AE, Erro R, Merola A, Fasano A, Berardelli A, Bhatia KP.

Mov Disord. 2017 Mar;32(3):325-331. doi: 10.1002/mds.26919. Epub 2017 Jan 24.

Management of sleep disorders in Parkinson's disease and multiple system atrophy

Videnovic A.

Mov Disord. 2017 May;32(5):659-668. doi: 10.1002/mds.26918. Epub 2017 Jan 24.

Parkinson's disease and transcranial pulsed electromagnetic fields: A randomized clinical trial

Morberg BM, Malling AS, Jensen BR, Gredal O, Bech P, Wermuth L.

Mov Disord. 2017 Apr;32(4):625-626. doi: 10.1002/mds.26927. Epub 2017 Jan 24.

Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features

Catalán MJ, Escribano PM, Alonso-Frech F.

Mov Disord. 2017 Apr;32(4):624-625. doi: 10.1002/mds.26903. Epub 2017 Jan 24.

Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-2016)

Galatsis P.

Expert Opin Ther Pat. 2017 Jun;27(6):667-676. doi: 10.1080/13543776.2017.1280464. Epub 2017 Jan 31.

Focused ultrasound treatment for central nervous system disease: neurosurgeon's perspectives

Chang WS, Chang JW.

Biomed Eng Lett. 2017 Jan 25;7(2):107-114. doi: 10.1007/s13534-017-0013-8. eCollection 2017 May.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias